Overview

Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy

Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
0
Participant gender:
All
Summary
This study is a double blinded randomized controlled trial evaluating the impact of tranexamic acid use on the transfusion rate in patients with complex kidney stones undergoing percutaneous nephrolithotomy.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Sao Paulo
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- Complex kidney stone (staghorn calculi GUYS III and IV)

Exclusion Criteria:

- Coronary artery disease - stent

- Severe chronic renal failure

- Congenital or acquired thrombophilia/thrombosis event

- Known or suspected allergy